Prevention of poststroke apathy using escitalopram or problem-solving therapy

American Journal of Geriatric Psychiatry

Volumn 21, Issue 9, 2013, Pages 855-862

  Mikami, Katsunaka ^a,f   Jorge, Ricardo E ^a   Moser, David J ^a   Arndt, Stephan ^a   Jang, Mijin ^a   Solodkin, Ana ^b   Small, Steven L ^c   Fonzetti, Pasquale ^d   Hegel, Mark T ^e   Robinson, Robert G ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Dartmouth Hitchcock Medical Center ^*  (United States)

^e DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^f TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apathy; Prevention; Stroke

Indexed keywords

ESCITALOPRAM; PLACEBO;

ADULT; AGED; ANOREXIA; ANORGASMIA; APATHY; ARTICLE; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; COMORBIDITY; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DISEASE SEVERITY; DRUG EFFICACY; DSM-IV; EJACULATION DISORDER; FEMALE; HAZARD RATIO; HUMAN; INDIGESTION; JUVENILE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NAUSEA; PATIENT ASSESSMENT; PHYSICAL DISEASE; PREVENTION STUDY; PROBLEM SOLVING; RANDOMIZED CONTROLLED TRIAL; TACHYCARDIA; THORAX PAIN;

APATHY; PREVENTION; STROKE;

AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; APATHY; CITALOPRAM; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PSYCHOTHERAPY; STROKE; TREATMENT OUTCOME;

EID: 84884551108     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2012.07.003     Document Type: Article

References (30)

1. Marin RS: Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 1991; 3: 243-254
2. Starkstein SE, Petracca G, Chemerinski E, et al: Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry 2001; 158: 872-877
3. Robert P, Onyike CU, Leentjens AF, et al: Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur Psychiatry 2009; 24: 98-104
4. Starkstein SE, Fedoroff JP, Price TR, et al: Apathy following cerebrovascular lesions. Stroke 1993; 24: 1625-1630
5. Levy R, Dubois B: Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex 2006; 16: 916-925
6. Marin RA, Chakravorty S: Disorders of diminished motivation, in Textbook of Traumatic Brain Injury. Edited by Silver JM, McAllister TW, Yudofsky SC. Washington, DC, American Psychiatric Publishing, 2005, pp 337-352
7. Kalivas PW, Volkow N, Seamans J: Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron 2005; 45: 647-650
8. Brodaty H, Sachdev PS, Withall A, et al: Frequency and clinical, neuropsychological and neuroimaging correlates of apathy following stroke: the Sydney Stroke Study. Psychol Med 2005; 35: 1707-1716
9. Mayo NE, Fellows LK, Scott SC, et al: A longitudinal view of apathy and its impact after stroke. Stroke 2009; 40: 3299-3307
10. Santa N, Sugimori H, Kusuda K, et al: Apathy and functional recovery following first-ever stroke. Int J Rehabil Res 2008; 31: 321-326
11. Robinson RG, Jorge RE, Moser DJ, et al: Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 2008; 299: 2391-2400
12. Mikami K, Jorge RE, Adams HP Jr, et al: Effect of antidepressants on the course of disability following stroke. Am J Geriatr Psychiatry 2011; 19: 1007-1015
13. Jorge RE, Acion L, Moser D, et al: Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry 2010; 67: 187-196
14. Robinson RG, Jorge RE, Clarence-Smith K, et al: Double-blind treatment of apathy in patients with poststroke depression using nefiracetam. J Neuropsychiatry Clin Neurosci 2009; 21: 144-151
15. Hegel MT, Barrett JE, Cornell JE, et al: Predictors of response to problem-solving treatment of depression in primary care. Behav Ther 2002; 33: 511-527
16. Mynors-Wallis LM, Gath DH, Lloyd-Thomas AR, et al: Randomised controlled trial comparing problem solving treatment with amitryptyline and placebo for major depression in primary care. BMJ 1995; 310: 441-445
17. Spitzer RL, Williams JBW, Gibbon M: Structured Clinical Interview for DSM-IV (SCID). New York, Biometric Research, New York State Psychiatric Institute, 1995
18. Hollingshead AB, Redlich FC: Social Class and Mental Illness: A Community Study. New York, Wiley, 1958
19. Forer S, Granger CV: Functional Independence Measure. Buffalo, NY, The Buffalo General Hospital State University of New York at Buffalo, 1987
20. Randolph C, Tierney MC, Mohr E, et al: Repeatable battery for the assessment of neuropsychological status. J Clin Exp Neuropsychol 1998; 20: 310-319
21. Lin DY, Wei LJ: The robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989; 84: 1074-1079
22. Mikami K, Jorge RE, Moser DJ, et al: Increased frequency of firstepisode poststroke depression after discontinuation of escitalopram. Stroke 2011; 42: 3281-3283
23. Narushima K, Paradiso S, Moser DJ, et al: Effect of antidepressant therapy on executive function after stroke. Br J Psychiatry 2007; 190: 260-265
24. Alexopoulos GS, Kiosses DN, Heo M, et al: Executive dysfunction and the course of geriatric depression. Biol Psychiatry 2005; 58: 204-210
25. Alexopoulos GS: Role of executive function in late-life depression. J Clin Psychiatry 2003; 64(suppl 14): 18-23
26. Jorge RE, Robinson RG: Escitalopram enhances cognitive recovery following stroke. Arch Gen Psychiatry 2010; 67: 187-196
27. Santarelli L, Saxe M, Gross C, et al: Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003; 301: 805-809
28. Rovner BW, Casten RJ, Hegel MT, et al: Preventing depression in age-related macular degeneration. Arch Gen Psychiatry 2007; 64: 886-892
29. Jorge RE, Starkstein SE, Robinson RG: Apathy following stroke. Can J Psychiatry 2010; 55: 350-354
30. Watanabe MD, Martin EM, DeLeon OA, et al: Successful methylphenidate treatment of apathy after subcortical infarcts. J Neuropsychiatry Clin Neurosci 1995; 7: 502-504